The MOSAIC trial is a landmark trial that established oxaliplatin + fluropyrimidine as the current standard of care for the adjuvant therapy in stage III #colon_cancer.
Watch this video to learn more.
#OncologyTrialAthlon
In the single center, randomized trial conducted in TATA Memorial hospital, 720 patients with TNBC were randomized to receive weekly paclitaxel plus carboplatin AUC2 vs paclitaxel alone weekly for 8 weeks. Both regimens were followed by 4 cycles of AC regimen every 2-3 weeks then surgery.
Oncologyme
/ Apr 30, 2023
.png)
